COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

PRS-343 in HER2-Positive Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03330561
Recruitment Status : Suspended (Partial clinical hold)
First Posted : November 6, 2017
Last Update Posted : August 25, 2020
Information provided by (Responsible Party):
Pieris Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : January 2021
Estimated Study Completion Date : May 2021